Back

Medscape, LLC

  • Antibodies, Monoclonal
  • Multiple Myeloma

Case-Based Guide for CD38-Targeted Monoclonal Antibody Therapy in the Treatment of Multiple Myeloma

The goal of this activity is for learners to be better able to individualize anti-CD38 monoclonal antibody (mAb)-based therapy by applying the latest clinical data including novel administration approaches to reduce patient- and practice-level burden.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

IPCE CreditsUp to 0.75 creditsAMA PRA Category 1 Credit™Up to 0.75 creditsNursingUp to 0.75 creditsPharmacyUp to 0.75 credits

MOC types

ABIM — Medical KnowledgeUp to 0.75 points

FDA REMS

No

Qualifies for MIPS

No

Pricing

Free

Reported to ACCME by the provider

  • Case-based learning
  • Credit · Up to 0.75 credits
  • MOC · Up to 0.75 points
  • Commercial Support
  • Released
    Jun 29, 2026
  • Last day to claim credit
    Jun 30, 2027 9 months left